Manmohan Singh, PhDChief Technology Officer at Beam TherapeuticsSpeaker
Profile
Dr.Manmohan Singh is currently the Chief Technology Officer at Beam Therapeutics in Cambridge, MA. Dr. Singh has over 28 years of R&D experience in drug product development, novel delivery systems, genetic medicines and vaccine research. He previously led technical teams overseeing early and late stage development programs at Takeda and Novartis. His team was instrumental in approval of several novel vaccines (FluAd®,Bexsero®,Menveo®,Flucelvax®). Dr. Singh has authored over 130 peer reviewed papers and is the editor of 6 Books on vaccines and drug product development. He was elected as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2011.
Agenda Sessions
Panel Discussion: Addressing the Challenges of Bringing New Therapeutic Modalities to Market: Technical and Regulatory Considerations
, 4:15pmView SessionChairman’s Remarks: Genome Editing Delivery
, 8:25amView SessionInnovations in Delivery Technologies to Advance Base Editing to the Clinic
, 9:00amView Session